AVAMAX

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 554892
                    [Title] => The other side of the coin
                    [Summary] => 
Last week, this column gave space to Pfizer, one of the parties in a controversial patent case against United Laboratories (Unilab).
                    [DatePublished] => 2010-03-06 00:00:00
                    [ColumnID] => 133753
                    [Focus] => 0
                    [AuthorID] => 1805279
                    [AuthorName] => Rey Gamboa
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 554987
                    [Title] => Unilab vs Pfizer: David at Goliath
                    [Summary] => 
NAKAKABILIB ang United Laboratories (Unilab), local na tagagawa ng gamot.
                    [DatePublished] => 2010-03-06 00:00:00
                    [ColumnID] => 133395
                    [Focus] => 0
                    [AuthorID] => 1804793
                    [AuthorName] => Al G. Pedroche
                    [SectionName] => PSN Opinyon
                    [SectionUrl] => opinyon
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 552870
                    [Title] => Lipitor vs Avamax
                    [Summary] => 
Let me get this straight before I even get to the details. I am not lobbying for any pharmaceutical company, multinational or otherwise.
                    [DatePublished] => 2010-02-27 00:00:00
                    [ColumnID] => 133753
                    [Focus] => 0
                    [AuthorID] => 1805279
                    [AuthorName] => Rey Gamboa
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 528038
                    [Title] => 'Evergreening' a blot on cheaper drugs law
                    [Summary] => 
President Gloria Arroyo confirmed yesterday her plan — reported last Sunday in Postscript — to run for the congressional seat in the second district of Pampanga now held by her son Juan Miguel (Mikey).
                    [DatePublished] => 2009-12-01 00:00:00
                    [ColumnID] => 135304
                    [Focus] => 0
                    [AuthorID] => 1804858
                    [AuthorName] => Federico D. Pascual Jr.
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

The other side of the coin

By Rey Gamboa | March 6, 2010 - 12:00am

Last week, this column gave space to Pfizer, one of the parties in a controversial patent case against United Laboratories (Unilab).

Business

Unilab vs Pfizer: David at Goliath

By Al G. Pedroche | March 6, 2010 - 12:00am

NAKAKABILIB ang United Laboratories (Unilab), local na tagagawa ng gamot.

PSN Opinyon

Lipitor vs Avamax

By Rey Gamboa | February 27, 2010 - 12:00am

Let me get this straight before I even get to the details. I am not lobbying for any pharmaceutical company, multinational or otherwise.

Business

'Evergreening' a blot on cheaper drugs law

By Federico D. Pascual Jr. | December 1, 2009 - 12:00am

President Gloria Arroyo confirmed yesterday her plan — reported last Sunday in Postscript — to run for the congressional seat in the second district of Pampanga now held by her son Juan Miguel (Mike...

Opinion